Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 1

A series of novel 3,4,5-trisubstituted aminothiophenes, as exemplified by compound 24, were designed, synthesized and evaluated as p53-MDM2 binding inhibitors.